药物警戒中智能自动化系统的验证:来自良好生产规范的启示
药物警戒需要监测药品效应以识别和评价潜在不良反应并及时提供风险控制措施。智能自动化技术有望自动化常规工作并平衡资源使用。本文提出三类智能自动化系统(从基于规则到动态AI系统),每类需独特验证方法,并扩展现有良好自动化生产规范,为药物警戒专业人员提供技术实施知识。
要点
- 智能自动化系统分三类,每类需独特验证方法。
- 现有验证要求基本不变,但需增加针对智能自动化的活动。
- 药物警戒专业人员需主导技术实施,确保检查准备和合规。
核心结论
- 智能自动化系统验证需在现有要求基础上增加针对智能自动化的活动以证明系统适用性。
- 三类智能自动化系统各需独特验证方法。
研究设计与样本
- 本文为药物警戒智能自动化系统验证的框架性论述,扩展了现有良好自动化生产规范。
主要发现
- 智能自动化技术有潜力自动化常规工作并平衡资源使用。
- AI可基于数据输入学习,但现有验证指南需增强以验证智能自动化系统。
- 验证要求基本不变,但需额外活动记录系统适用性证据。
关键数值与推荐
- 提出三类智能自动化系统:从基于规则系统到动态AI系统,每类需独特验证方法。
- 扩展现有良好自动化生产规范,该规范概述了针对人工智能静态系统的基于风险的方法。
临床怎么用
- 药物警戒专业人员应主导组织内技术实施,考虑辅助技术系统的构建、实施、验证和维护。
- 专业人员需弥合业务运营与技术进展之间的差距,确保检查准备和符合全球监管机构要求。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Pharmacovigilance is the science of monitoring the effects of medicinal products to identify and evaluate potential adverse reactions and provide necessary and timely risk mitigation measures. Intelligent automation technologies have a strong potential to automate routine work and to balance resource use across safety risk management and other pharmacovigilance activities. While emerging technologies such as artificial intelligence (AI) show great promise for improving pharmacovigilance with their capability to learn based on data inputs, existing validation guidelines should be augmented to verify intelligent automation systems. While the underlying validation requirements largely remain the same, additional activities tailored to intelligent automation are needed to document evidence that the system is fit for purpose. We propose three categories of intelligent automation systems, ranging from rule-based systems to dynamic AI-based systems, and each category needs a unique validation approach. We expand on the existing good automated manufacturing practices, which outline a risk-based approach to artificially intelligent static systems. Our framework provides pharmacovigilance professionals with the knowledge to lead technology implementations within their organizations with considerations given to the building, implementation, validation, and maintenance of assistive technology systems. Successful pharmacovigilance professionals will play an increasingly active role in bridging the gap between business operations and technical advancements to ensure inspection readiness and compliance with global regulatory authorities.
引用
- Huysentruyt K, Kjoersvik O, Dobracki P, et al. Validating Intelligent Automation Systems in Pharmacovigilance: Insights from Good Manufacturing Practices. Drug Saf. 2021. PMID: 33523400. doi:10.1007/s40264-020-01030-2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。